ProfileGDS5678 / 1457750_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 17% 17% 17% 18% 16% 17% 18% 17% 17% 16% 16% 16% 17% 16% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4328617
GSM967853U87-EV human glioblastoma xenograft - Control 22.4083417
GSM967854U87-EV human glioblastoma xenograft - Control 32.4087117
GSM967855U87-EV human glioblastoma xenograft - Control 42.3806518
GSM967856U87-EV human glioblastoma xenograft - Control 52.3435616
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4620217
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4756318
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.390717
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.383817
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.3896316
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.3911516
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.3708916
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.4051917
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.3963216